3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Breast Neoplasms
3
Neoplasm Metastasis
2
Leukemia, B-Cell
2
Urinary Bladder Neoplasms
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hyperparathyroidism, Primary
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Carcinoma, Renal Cell
1
Carcinoma
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
pazopanib
4
tazemetostat
3
Doxorubicin
3
cixutumumab
2
Sorafenib
2
Radiotherapy
2
Radiation
2
Interferon-gamma
2
Ifosfamide
2
Gemcitabine
2
tremelimumab
1
temsirolimus
1
sapanisertib
1
romidepsin
1
pembrolizumab
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
interferon gamma-1b
1
indolepropanol phosphate
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sunitinib
1
Rifampin
1
Razoxane
1
Ramucirumab
1
Radiotherapy, Conformal
1
Observation
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Synovial
×
Tablets
×
Clear all
No trials found.